Riskpilot← Back to searchSign inGet full accessAtom Medical AB
ABActiveOrg 5569910903Tuve Kyrkväg 186General medical practice activities · NACE 8621Est. 20141 employees
Revenue 2024
SEK 437K
-14% vs 2023
EBITDA margin
8.5%
+1333% vs 2023
Equity ratio
46.9%
Financial strength
Net profit 2024
SEK 29K
+825% vs 2023
| Revenue | SEK 437K | -14% |
| EBITDA | SEK 37K | +1333% |
| Net profit | SEK 29K | +825% |
| Total assets | SEK 254K | +22% |
| Equity | SEK 119K | +32% |
| Employees | 1 | — |
Legal name
Atom Medical AB
Org number
5569910903
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
19 november 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall erbjuda tjänster inom vård och medicinsk verksamhet, samt äga och driva butiksverksamhet inom livsmedel. Bolaget ska även bedriva bemanningsverksamhet och uthyrning av personal samt tillhandahålla personal för event, mässor, konferenser och företagsevenemang samt därmed förenlig verksamhet.
Address
Tuve Kyrkväg 186
Email
furqan.attar@googlemail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 963 | 408 | 136 | 506 | 437 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 18 | −30 | −121 | −3 | 37 |
| Depreciation & amort. | −43 | −4 | −4 | −0 | −0 |
| EBIT | −25 | −34 | −125 | −3 | 37 |
| Net financials | −1 | — | −2 | 1 | — |
| Profit before tax | −6 | 0 | −55 | −3 | 37 |
| Tax | −0 | −1 | −1 | −1 | −8 |
| Net profit | −6 | −1 | −56 | −4 | 29 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 527 | 401 | 156 | 209 | 254 |
| Equity | 150 | 150 | 93 | 90 | 119 |
| Long-term debt | 8 | 0 | 0 | 0 | 0 |
| Short-term debt | 262 | 180 | 63 | 120 | 135 |
| Total debt | 270 | 180 | 63 | 120 | 135 |
EBITDA margin
8.5%
This company
15.8%
Market median
-46% vs market
20202024
Equity ratio
46.9%
This company
38.2%
Market median
+23% vs market
20202024
Return on equity
24.4%
This company
18.4%
Market median
+33% vs market
20202024
Net profit margin
6.6%
This company
8.1%
Market median
-19% vs market
20202024
Asset turnover
1.72×
This company
1.12×
Market median
+54% vs market
20202024
Debt / equity
1.13×
This company
0.62×
Market median
-82% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Atom Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Furqan Al-Attar | Chief Executive Officer | 0 companies |
| Tamara Al-Kubaisi | Deputy Board Member | 0 companies |